Insulet (PODD) EPS (Basic) Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 49.78% |
| Sep 30, 2025 | 47.11% |
| Jun 30, 2025 | 7.78% |
| Mar 31, 2025 | 79.56% |
| Dec 31, 2024 | 78.26% |
| Sep 30, 2024 | 156.49% |
| Jun 30, 2024 | 166.53% |
| Mar 31, 2024 | 60.26% |
| Dec 31, 2023 | 54.16% |
| Sep 30, 2023 | 89.86% |
| Jun 30, 2023 | 71.88% |
| Mar 31, 2023 | 38.47% |
| Dec 31, 2022 | 32.50% |
| Sep 30, 2022 | -14.87% |
| Jun 30, 2022 | -30.92% |
| Mar 31, 2022 | 34.20% |
| Dec 31, 2021 | 36.20% |
| Sep 30, 2021 | 41.14% |
| Jun 30, 2021 | -35.84% |
| Dec 31, 2020 | 11.54% |
| Sep 30, 2020 | 20.71% |
| Jun 30, 2020 | 22.28% |
| Mar 31, 2020 | 30.12% |
| Dec 31, 2019 | 22.87% |
| Sep 30, 2019 | 15.47% |
| Jun 30, 2019 | 15.30% |
| Mar 31, 2019 | 21.40% |
| Dec 31, 2018 | 44.27% |
| Sep 30, 2018 | 15.74% |
| Jun 30, 2018 | 31.57% |
| Mar 31, 2018 | 11.27% |
| Dec 31, 2017 | 10.59% |
| Sep 30, 2017 | 31.23% |
| Jun 30, 2017 | 15.40% |
| Mar 31, 2017 | 11.32% |
| Dec 31, 2016 | 11.81% |
| Sep 30, 2016 | 29.64% |
| Jun 30, 2016 | 13.99% |
| Mar 31, 2016 | 2.89% |
| Dec 31, 2015 | 0.81% |
| Sep 30, 2015 | -1.30% |
| Jun 30, 2015 | 3.58% |